Company Overview and News

35
Smith Micro Software Turns Profitable

2018-09-20 seekingalpha
The company managed to squeeze its first (non-GAAP) profitability in quite a while and things look set to improve from here.
CHTR S CMCSA SMSI

8
Amazon Partner Baristas adds Major League Baseball, Fox Sports, ESPN News, BBC America and 19 other Networks in White Coffee Marketing Saturation Throughout LA Featuring Music Sensation Megs McLean Capitalizing on NFL Marketing Success

2018-09-20 globenewswire
Baristas and Fulfillment partner Amazon has expanded Its TV advertising campaign saturating LA adding MLB Network, in White Coffee spots
CHTR DISH BCCI

76
Before And After The Sector Shakeup In The S&P 500 - Part 2

2018-09-19 seekingalpha
In part 1 of this post, the current sector weights, returns, and correlations of the S&P 500 are shown, as well as a map depicting the expanded telecommunication services sector into communication services. Now, here's a deeper dive into what is moving and its impact.
FB DISH CMCSA TRIP NFLX GOOG CHTR AMZN T GOOGL TWTR AAPL VZ DIS EBAY

10
Bulletproof Investing Performance Update, Week 42

2018-09-18 seekingalpha
It has been six months since I presented four hedged portfolios and 10 top names in week 42 of my Marketplace service (March 15). Here's how everything did.
BURL VRNT NFLX CMD CHE RHT W CMN CHTR GTT GWW EPAM TWTR

 
Goldman Sachs Very Bullish on 4 Top Telecom, Cable and Tower Stocks

2018-09-17 247wallst
Needless to say, the telecom and content revolution, which has been spurred on by the leaps and bounds in the wireless industry, are changing the way everything is viewed and packaged now. The days of the cable company or satellite provider dictating which content will be presented are over, as over-the-top streaming of programming has become a huge force in the industry.
CHTR ATUS ALV.WI

11
Amazon, Apple, others to testify before US Senate on data privacy on September 26

2018-09-12 channelnewsasia
Executives from AT&T Inc, Twitter Inc, Alphabet Inc's Google, Amazon.com Inc, Apple Inc and Charter Communications Inc are scheduled to testify about consumer data privacy before a U.S. Senate panel on Sept. 26, according to a congressional statement.
CHTR EFX GOOGL TWTR AAPL GOOG

11
Amazon, Apple, others to testify before US Senate on data privacy om September 26

2018-09-12 channelnewsasia
Executives from AT&T Inc, Twitter Inc, Alphabet Inc's Google, Amazon.com Inc, Apple Inc and Charter Communications Inc are scheduled to testify about consumer data privacy before a U.S. Senate panel on Sept. 26, according to a congressional statement.
CHTR GOOGL TWTR AAPL GOOG

11
Amazon, Apple, others to testify before US Senate on data privacy September 26

2018-09-12 channelnewsasia
Executives from AT&T Inc, Twitter Inc, Alphabet Inc's Google, Amazon.com Inc, Apple Inc and Charter Communications Inc are scheduled to testify about consumer data privacy before a U.S. Senate panel on Sept. 26, according to a congressional statement.
CHTR GOOGL TWTR AAPL GOOG

11
Amazon, Apple, others to testify before U.S. Senate on data privacy Sept 26

2018-09-12 reuters
WASHINGTON (Reuters) - Executives from AT&T Inc, Twitter Inc, Alphabet Inc’s Google, Amazon.com Inc, Apple Inc and Charter Communications Inc are scheduled to testify about consumer data privacy before a U.S. Senate panel on Sept. 26, according to a congressional statement.
CHTR GOOGL TWTR AAPL GOOG

1
With Les Moonves out, CBS is more likely than ever to join Viacom

2018-09-10 cnbc
Departing CBS CEO Les Moonves stopped CBS from merging with Viacom. Now that he's gone, the third time could be the charm, according to analysts.
CHTR TWX TWC

7
Top Analyst Reports for Berkshire Hathaway, Coca-Cola & Disney

2018-09-10 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Coca-Cola (KO) and Disney (DIS). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
BLT BHPBF PANW ZTS BRK.A CHTR BHP KHC BBL BHP BHPLF FIVE

5
Top Research Reports for Abbott, Gilead & FedEx

2018-09-07 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Abbott (ABT), Gilead (GILD) and FedEx (FDX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
NRGEO NRG CHTR CBG UPS KHC FDX CBRE

10
Top Stock Reports for Chevron, U.S. Bancorp & Kraft Heinz

2018-09-06 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Chevron (CVX), U.S. Bancorp (USB) and Kraft Heinz (KHC). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
USB CHTR GIS XOM CVX WDAY KHC

16
Top Analyst Reports for Pfizer, Salesforce & ADP

2018-09-05 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer (PFE), Salesforce (CRM) and ADP (ADP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
CHTR ACN GM PFE

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CHTR / Charter Communications, Inc. on message board site Silicon Investor.

Charter Communications (CHTR) Charter Communications (CHTR) Charter Communications (CHTR) Charter Communications (CHTR) Charter Communications (CHTR) Charter Communications (CHTR)
Richtree- Marche Movenpick of North America Richtree- Marche Movenpick of North America Richtree- Marche Movenpick of North America
CUSIP: 16119P108